Sign in

NCT07129915Recruiting

Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial

Effect of Nudge-Based Shared Decision Making on Self-Management Among Patients With Type 2 Diabetes: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 28 Nov 2025

Brief summary (registry, in English)

This study aims to test whether a communication strategy called "linguistic nudging" can help doctors and patients with type 2 diabetes make better treatment decisions together, and whether this improves patients' ability to manage their condition. What will happen in the study? - 250 adults with type 2 diabetes from Xiang'an Hospital (Xiamen) will be randomly assigned to one of two groups: Intervention group:Doctors will receive special training in "linguistic nudging" techniques to encourage shared decision-making. Patients will use a mobile app to record medication preferences, and doctors will adjust advice based on these preferences. Control group:Patients will receive standard diabetes care without these additional strategies. - All participants will be followed for 6 months. What is the study aiming to find out? The main goal is to see if patients in the intervention group: Better follow medication plans Improve blood sugar monitoring Have better blood sugar control Feel more satisfied with doctor-patient communication Why is this important? Good self-management is key to controlling diabetes, but many patients struggle with it. Effective communication during shared decision-making may empower patients to manage their condition day-to-day with greater confidence. Patient safety and rights: Participation is completely voluntary All personal information will be kept strictly confidential Medical support will be provided if any health problems occur during the study Participants may withdraw at any time This research has been approved by the Ethics Committee of Xiang'an Hospital (Approval date: October 2025).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
250 (estimated)
First submitted
1 Aug 2025
Start date
1 Nov 2025
Primary completion date
31 May 2026
Lead sponsor
Yunxuan Li
NCT number
NCT07129915

What you commit to

  • Study type: Interventional
  • Planned participants: 250
  • From 1 Nov 2025 to the primary completion date, 31 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Documented cognitive impairment (dementia, Alzheimer's, etc.)

Other

  • Severe acute complications (e.g., ketoacidosis, hyperosmolar coma)
  • Currently participating in other clinical trials
  • Life expectancy < 6 months
  • Pregnancy or lactation

Who the study is looking for

  • Confirmed diagnosis of type 2 diabetes
  • Age ≥ 18 years
  • Normal cognitive function (assessed by Mini-Cog score ≥ 3)
  • Basic smartphone operation ability (can independently use WeChat)
  • Willing to participate and sign informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Xiang'an Hospital Affiliated to Xiamen University
Coordinator of this site? Confirm its status
XiamenChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.